
What's Changing with Medicare Costs in 2027
The Centers for Medicare & Medicaid Services (CMS) has proposed policy updates designed to lower what you pay out of pocket for certain outpatient imaging services, like MRIs and CT scans, along with specific outpatient drugs covered under Medicare Part B. These changes are closely tied to CMS's site-neutral payment policy and the Outpatient Prospective Payment System (OPPS), the mechanisms CMS uses to set how much hospitals and other outpatient facilities are paid for these services, and in turn, how much beneficiaries owe in cost-sharing. These changes are aimed at reducing coinsurance costs and making your medical bills easier to predict ahead of time. As of this writing, CMS has not published a final rule with a specific Federal Register notice number and publication date confirming this policy as finalized; it should be treated as proposed or under consideration rather than locked in. For the current status, specific rule text, and effective dates, see the official notices on federalregister.gov or the corresponding rule page on CMS.gov.
It helps to know the timing here. These updates, if finalized, would take effect in 2027, not right away, so your 2026 costs for imaging and Part B drugs remain exactly as they are today. Nothing changes on your current bills this year.
CMS has framed this adjustment as a response to growing patient cost-sharing on high-cost outpatient services. The goal is simpler and more consistent billing, so you have a clearer sense of what a scan or infusion will actually cost before you receive care.
Key Takeaways
- CMS finalized new rules capping coinsurance for select outpatient imaging services (MRIs, CT scans) and Part B drugs starting in 2027
- No changes apply in 2026; current cost-sharing rules remain in effect until the new policy takes effect
- The update changes how cost-sharing is calculated, not what Medicare covers, moving toward standardized, capped amounts instead of straight 20% coinsurance
- Hospital outpatient imaging may see the biggest cost difference since it historically carries higher cost-sharing than independent imaging centers
- CMS has not yet published final capped dollar amounts for every affected service
Why This Policy Update Exists
Coinsurance on outpatient imaging and Part B drugs has been rising for years, and for many beneficiaries, a single MRI or infusion visit can carry a cost-sharing bill that is hard to anticipate. Research from organizations such as MedPAC and KFF has tracked this trend, pointing to growing out-of-pocket cost-sharing for outpatient services over time; you can review their published analyses at medpac.gov and kff.org for more detail. For example, MedPAC's annual data book on Medicare and the health care delivery system has reported average Medicare-allowed charges for outpatient imaging services such as MRI and CT scans, illustrating just how widely billed amounts can vary by facility and region, a key reason CMS has cited for pursuing more standardized cost-sharing. Under standard Medicare Part B, you typically pay 20% coinsurance after meeting your annual Part B deductible, which is set each year by CMS and published at CMS.gov, and that percentage can translate into very different dollar amounts depending on the total charge for the service.
CMS is addressing this by proposing to adjust how payment and cost-sharing are calculated for these specific services, not by reducing what Medicare covers. The services themselves remain covered benefits; what would change is the formula behind your share of the cost.
This update is part of a larger pattern of CMS reviewing high-cost outpatient categories for affordability concerns, consistent with its ongoing work on Medicare payment policy, including site-neutral payment policy and OPPS rate-setting, published through annual rule updates at CMS.gov.
How the Changes Affect Imaging Services
Which Imaging Services Are Included
The 2027 changes, if finalized as proposed, would apply to a defined set of outpatient diagnostic imaging services commonly ordered to evaluate conditions like joint pain, cardiac issues, or cancer staging. These include:
MRI scans
CT scans
PET scans
Certain advanced diagnostic imaging performed in outpatient settings
If you receive imaging through a hospital outpatient department rather than an independent imaging center, you may notice the largest cost difference, since hospital outpatient billing has historically carried higher cost-sharing under Part B.
What You Might Notice on Your Bill
Instead of paying a straight 20% coinsurance on the full charge for a scan, the proposed structure moves toward standardized, capped cost-sharing amounts for included imaging services. This means your share would be less dependent on the total billed amount and more predictable regardless of which outpatient facility performs the scan, if this policy is finalized as described.
A capped cost-sharing structure sets your out-of-pocket share at a fixed amount instead of a percentage of the total bill, so what you owe stays the same no matter how much the facility charges. For example, imagine an outpatient MRI billed at $1,200. Under today's standard 20% coinsurance, you would owe roughly $240 for that single scan after meeting your deductible. Under a capped cost-sharing approach, your share would instead be set at a fixed amount regardless of the total charge, so if that cap were, say, $150, you would owe $150 whether the MRI was billed at $1,200 or at a higher or lower amount. This is only an illustration to show how a cap could work. CMS has not published final capped amounts for every service, and this policy has not been confirmed as finalized, so no specific dollar figures should be assumed until those details are released.
Check Your Statements
Once the 2027 changes take effect, compare the coinsurance line items on your Medicare Summary Notice against prior statements for the same type of service. This is the clearest way to see the real dollar impact on your own bills.
How the Changes Affect Outpatient Drug Costs
Which Drugs Are Covered Under This Change
This part of the update applies specifically to Part B drugs, meaning medications administered in a clinical setting such as a doctor's office or outpatient infusion center. It does not apply to Part D prescription drugs you pick up at a pharmacy.
Common examples include chemotherapy infusions and biologic injectables given during an office visit. These drugs are typically billed differently than retail prescriptions, with cost-sharing tied to the Part B deductible and coinsurance structure rather than a Part D copay tier.
Covered under this change: chemotherapy infusions given in a clinical setting
Covered under this change: biologic injectables administered during an office visit
Not covered under this change: Part D retail prescription drugs picked up at a pharmacy
Not covered under this change: over-the-counter medications
Expected Savings and Limitations
How much you might save depends heavily on which drug you receive and how often you need treatment. A single annual infusion will see a smaller cumulative benefit than a drug administered weekly or monthly, since the adjusted cost-sharing applies per claim.
If you have supplemental coverage, such as a Medigap plan, your out-of-pocket responsibility may already be reduced for Part B coinsurance, which means the practical effect of this federal change could look different depending on your existing coverage. It's worth understanding both pieces together rather than assuming the new rule is the only factor at play.

If you're weighing whether to adjust your coverage before 2027, don't make that decision based on this policy alone. Look at your full picture first, including your current Medigap or Medicare Advantage cost-sharing for imaging and infusions, since the federal change may simply layer on top of protections you already have.
Does This Change Affect Enrollment Deadlines or Penalties
This update is strictly a billing and cost-sharing change. It does not alter your enrollment deadlines, Special Enrollment Periods, or any late enrollment penalties tied to Part B, Part D, or Medigap. If you are approaching an enrollment deadline for any part of Medicare, that timeline continues on its normal schedule regardless of these proposed 2027 cost-sharing updates.
If you're unsure about your own enrollment timing, it's worth confirming your dates separately rather than assuming this policy changes anything about when you need to sign up or switch coverage. You can confirm your personal enrollment windows through Medicare.gov or by speaking with a licensed Medicare agent.
What to Watch for in Your Future Medicare Billing Statements
Once the 2027 rules are active, a periodic review can help confirm savings are actually showing up and catch any billing mistakes early. Consider these steps each time you receive a statement for imaging or an outpatient drug claim:
Review your Medicare Summary Notice for updated coinsurance amounts tied to imaging or Part B drug claims.
Compare the new costs against prior statements from the same provider for a similar service.
Confirm your provider has updated their HCPCS/CPT billing codes to reflect the new payment structure.
Contact Medicare or your plan directly if a charge looks incorrect or doesn't match what you expected.
This kind of regular check is useful beyond just tracking savings. Reviewing your statements closely is one of the most reliable ways to catch a billing error before it becomes a larger dispute, something the [Medicare Summary Notice](https://www.medicare.gov/) is specifically designed to help you do.
How These Changes Fit Into Your Overall Medicare Planning
A federal payment change like this is a good prompt to revisit your broader coverage choices, particularly during your next opportunity to review Medigap or Medicare Advantage options. Since cost-sharing formulas are shifting for specific services, it's worth asking whether your current plan still matches how you use imaging and outpatient drug services.
Not every plan will see the same benefit from these changes. Medicare Advantage plans set their own cost-sharing structures within federal guidelines, so the practical savings from this update could look different depending on your specific plan's existing rules for imaging and infusions.
A licensed Medicare agent can help translate what this federal policy update means for your specific coverage, since they can look at your plan's current cost-sharing rules alongside these new CMS changes.
Frequently Asked Questions
Do I need to do anything right now to benefit from these 2027 changes?
Will someone try to sell me a new plan because of this policy update?
Can I just read more about this later and decide if it affects me?
How do I know if this information is accurate and not outdated?
Your Next Step Toward Lower Medicare Costs
These proposed 2027 changes are meant to ease the financial strain of outpatient imaging and certain Part B drug costs, and they don't require you to act immediately. What they do offer is a window of time to look closely at your current coverage and ask questions before any new cost-sharing rules take effect.
Use this period to review how your plan currently handles imaging and infusion costs, and consider whether your coverage still fits your needs. If you'd like a clearer picture of how these updates may apply to your specific situation, a licensed Medicare agent can walk through your plan with you, with no pressure to make changes before you're ready.
Related Articles
Have Medicare questions?
Our licensed Medicare agents are available to help you find the right coverage.


